Didushko, O. M. “ADVANTAGES OF EARLY COMBINED THERAPY WITH VILDAGLIPTIN AND METFORMIN IN PATIENTS WITH TYPE 2 DEABETES MELLITUS ”. Problems of Endocrine Pathology, vol. 73, no. 3, Aug. 2020, pp. 136-42, doi:10.21856/j-PEP.2020.3.17.